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Each year in the US,∼1.5 million people sustain a traumatic brain injury (TBI). Victims ofTBI
can suffer from chronic post-TBI symptoms, such as sensory and motor deficits, cognitive
impairments including problems with memory, learning, and attention, and neuropsychi-
atric symptoms such as depression, anxiety, irritability, aggression, and suicidal rumination.
Although partially associated with the site and severity of injury, the biological mechanisms
associated with many of these symptoms – and why some patients experience differing
assortments of persistent maladies – are largely unknown. The use of animal models is a
promising strategy for elucidation of the mechanisms of impairment and treatment, and
learning, memory, sensory, and motor tests have widespread utility in rodent models ofTBI
and psychopharmacology. Comparatively, behavioral tests for the evaluation of neuropsy-
chiatric symptomatology are rarely employed in animal models ofTBI and, as determined in
this review, the results have been inconsistent. Animal behavioral studies contribute to the
understanding of the biological mechanisms by which TBI is associated with neurobehav-
ioral symptoms and offer a powerful means for pre-clinical treatment validation.Therefore,
further exploration of the utility of animal behavioral tests for the study of injury mecha-
nisms and therapeutic strategies for the alleviation of emotional symptoms are relevant
and essential.
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INTRODUCTION
Traumatic brain injury (TBI) is associated with a range of post
injury complaints, and currently there are no fully effective ther-
apies for most of these symptoms (1–4). The lack of effective
therapies, the vast number of affected individuals worldwide, the
loss of earning power, the cost for care, and the rehabilitative needs
of patients affirms that research is essential for expanding our
understanding of the pathophysiology of TBI and for developing
effective treatments.
A promising strategy for the identification of the biological
mechanisms underlying TBI symptomatology and facilitating the
search for effective therapies is the use of animal models. Pre-
vious reviews have well described the fact that the complexity
of TBI makes it difficult for a single animal model to repro-
duce the entire range of symptoms that occur post-TBI (5–9).
Yet, animal models can mimic some of the human conditions
resulting from forceful collision, non-impact acceleration, blast
wave exposure, and polytraumatic events [for review, see Ref.
(6)]. There are several previous, excellent reviews addressing ani-
mal models of TBI and behavior (10–13). However, the focus
was primarily on cognitive and/or motor symptoms, with less
attention to the neuropsychiatric symptoms frequently identi-
fied in post-TBI patients. This review focuses on the status
of behavioral tests used in rodents to model depression, anx-
iety, irritability, aggression, and suicidal behaviors associated
with TBI.
HUMAN TBI: THE EXTENT OF THE PROBLEM
Traumatic brain injury is a general term for a spectrum of focal and
diffuse cerebral insults that result from sudden impact, changes
in inertial forces, penetrating wounds, hypoxic and toxic meta-
bolic insults, and vascular injuries of the cerebrum. Analysis of the
causes and consequences of traumatic brain injuries is tradition-
ally seen as occurring in two phases: (1) primary injury – arising
from the aforementioned changes and (2) secondary injury – the
biochemical and physiological brain changes caused by the pri-
mary injury, including excitotoxicity and energy failure, ischemia,
cell death, edema, delayed axonal injury, and inflammation.
In 1999, the Centers for Disease Control and Prevention rec-
ognized the medical, economic, personal, and domestic conse-
quences of TBI (14). Termed “a silent epidemic,” each year in the
US, over 1.5 million people sustain a TBI (15). About 70–90% of
these injuries are described as mild (16), although the percentage
may be greater than this estimate with consideration that some
victims do not receive treatment. Principally resulting from vehic-
ular and home accidents or sports injuries (17), there has been
continued discussion of what constitutes “mild TBI,” where com-
plaints may include headaches, dizziness, mental “cloudiness,” a
brief loss of consciousness, and post-traumatic amnesia [see Ref.
(18) for further discussion of definitions]. TBI is also one of the
most common injuries among US military and civilian personnel,
where in the last decade an estimated 15–20% of soldiers experi-
enced mild TBI during deployment mainly due to explosives and
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blast injuries (19), and almost 80% of these insults were diagnosed
as mild (20).
For milder cases, the complaints usually diminish with time.
Bruns and Jagoda (21), for example, cite earlier work that >58%
of mild TBI victims manifest symptoms at 1 month after injury
(22), but that the percentage declines to 15% by 1 year after injury
(23). The latter, however, even for mild TBI cases, is a “non-
trivial minority” (19). These cognitive, emotional, behavioral, and
somatic problems can be debilitating and a substantial source of
stress to TBI survivors and their families (24).
While there is less evidence of such long-term effects from
mild injuries, neurodegenerative disorders have been associated
with moderate and severe TBI (25, 26). For example, Bazar-
ian and colleagues reviewed 75 reports regarding the long-term
effects (defined as present at least 6 months post injury) from
TBI (25). Dementia of the Alzheimer’s type, Parkinson’s disease,
and endocrine disorders were associated with moderate and severe
TBI. Post-traumatic seizures were also associated with TBI, espe-
cially if the injury was a penetrating event. For mild TBI, this
group reported previous work indicating a diversity of complaints
including, memory impairment, dizziness, headache, difficulties
with attention, sleep disturbances, depression, anxiety symptoms,
reduced stress tolerance, apathy, a lack of spontaneity, emotional
excitability, and irritability (25).
Recent publications have underlined the serious, long-term
effects of repeated “mild” trauma. Although much work needs
to be done to define many of the specific contributors to the
insidious effect from head impacts, there is evidence that repeated
injuries from sport activities and possibly blast exposures, seem-
ingly inconsequential at the time, are antecedent conditions for
mood and cognitive impairments. In addition to a higher inci-
dence of Alzheimer disease, it has been recognized that chronic
traumatic encephalopathy is associated with repetitive “mild”
impacts (27, 28).
Although treatment and rehabilitation of TBI has primarily
focused on sensory, motor, and cognitive symptoms, co-morbid
neuropsychiatric disorders (see Table 1 for a summary of the core
features) that give rise to emotional and behavioral difficulties
significantly impair the quality of the lives of patients and even
can lead to suicide behavior (29, 30). To provide context for how
behavioral testing can be employed to study post-TBI-like symp-
toms in pre-clinical rodent models, the clinical phenotypes are
briefly reviewed. Rodent behavioral tests purportedly related to
each of the aforementioned neuropsychiatric dimensions are then
described, and the test’s utility in TBI research is reviewed. In
general, results from the evaluation of neuropsychiatric symp-
toms in pre-clinical models have been limited. It is proposed
that further validation is needed to relate pre-clinical models with
TBI-associated neuropsychological systems.
DEPRESSION SYMPTOMS
The most common psychiatric complaint in patients with mild
TBI is depression (19, 31). The reported prevalence of depression
varies between studies, and ranges from 10 to 77% (32–34). Several
factors contribute to the reported variability of post-TBI depres-
sion, including differences in diagnostic criteria, severity of the
TBI, the time after TBI when the diagnosis is made, and diversity
in patient populations (33). Rates of depression in patients with
TBI are highest in the first year after the injury is sustained (35),
but the risk for the appearance of depression remains elevated even
decades after injury (36).
The primary symptoms of depression following TBI include
episodes of sadness, negativism, loss of pleasure, feelings of
hopelessness, suicidal thoughts, and sometimes psychosis (37).
Victims often experience increased psychological distress and
poor psychosocial status (38). In addition, depression is asso-
ciated with a greater number and perceived severity of a vari-
ety of so-called post-concussive symptoms including, headache
and dizziness complaints, irritability and memory problems, and
sensory system-related complaints of irritability with lights and
noises (39, 40).
ANXIETY SYMPTOMS
Anxiety disorders develop in 10–70% of patients with a mild TBI
(19, 37, 41). As with depression, the wide range of reported preva-
lence is due to the nature of data collection, the severity of the
brain injury, and confounding effects of demographic factors. Sil-
ver and colleagues (29) found (after adjusting for the potentially
confounding effects of demographic factors, quality of life, and
alcohol abuse) that individuals who experienced TBI reported a
higher prevalence of panic disorder and phobic disorder compared
to the control group. Fann and colleagues (39) found that 24%
of outpatients with TBI had generalized anxiety disorder, while
Jorge and colleagues (35) reported that 11% of the patients with
TBI developed generalized anxiety disorder in addition to major
depression. The core features of anxiety following TBI include
Table 1 |Traumatic brain injury-related neuropsychiatric symptoms.
Post-TBI symptoms Prevalence (%) Core features
Depression 10–77 Episodes of sadness, loss of pleasure, negativism, feeling of hopelessness, and suicide thoughts
Anxiety 10–70 Feeling of apprehension or dread with or without autonomic signs and symptoms. Anxiety with feelings of
re-experiencing trauma, avoidant behavior, emotional numbing
Irritability 15–37 Reduced control over temper which usually results in irascible verbal or behavioral outbursts
Aggression 11–34 Destructive behaviors toward individuals or property; behaviors, attitudes, or moods that others perceive as
threatening; and/or purposeful attempts to disrupt rehabilitation and discharge from hospital
Suicidality 1–17 High rates of critical indicator of suicide risk, including: hopelessness, suicide ideation, and suicide attempts
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feelings of apprehension or dread with or without autonomic
signs and symptoms. Post-traumatic stress disorder (PTSD) is also
commonly experienced by victims of TBI, and is described as anx-
iety with feelings of re-experiencing trauma, avoidant behavior,
emotional numbing, and hypervigilance (37).
IRRITABILITY
A prevalent post-TBI neuropsychiatric symptom is irritability (42–
44). Irritability can be defined as “a feeling state characterized by
reduced control over temper which usually results in irascible ver-
bal or behavioral outbursts, although the mood may be present
without observed manifestation” (45). One study found that more
than 37% of the patients between the ages 18 and 65 suffered
from irritability post-TBI (42), and another study indicated irri-
tability is one of the most frequently reported symptoms by TBI
patients, and that this symptom remains notable even 10 years
after injury (46). Furthermore, several studies of irritability indi-
cate it as one of the major risk factors for suicidality (47), and has a
strong association with suicidal ideation and suicide attempts (48,
49). Irritability can have a significant toll on the wellbeing of the
patient and their family; it often dwells in the family system and
has a life-changing impact on martial relationships (50).
AGGRESSION
Within the Hostility Inventory developed by Buss and Durkee
(51), irritability was recognized as one of the major components
of an “aggression” factor. Behavioral responses to irritable states
include verbal and physical aggression that contribute significantly
to social and family difficulties experienced by patients with TBI
(52). Broadly defined, aggression in humans is “destructive behav-
iors toward individuals or property; behaviors, attitudes, or moods
that others perceive as threatening; and/or purposeful attempts to
disrupt rehabilitation and discharge from hospital” (53, 54). There
is a wide range in the current estimates of the presence of aggres-
sion in TBI patients and in a critical review of the literature, Kim
and colleagues (55) concluded that these estimations are limited
by a lack of a rigorous definition of the term “aggression,” as well
as inconsistent methodology for identifying aggressive behaviors.
In addition, family-reported aggression tends to be higher than
self-reported aggression (44, 56), contributing to variability in
summaries of prevalence.
Nevertheless, there is agreement that TBI increases the risk of
aggressive behavior and some findings remain consistent in studies
of post-TBI aggression. Aggressive behavior shows a high asso-
ciation with mood disorders and substance abuse (57, 58) and
other co-morbid problems that were present before the injury
(57). A prior-injury history of aggression was also highly cor-
related with post injury aggressive behaviors (52, 54). Of some
fortune, aggressive behaviors displayed by brain-injured patients
were most often characterized by expressions of anger and threats
of violence rather than actual physical violence (58). In addition
to the challenges aggressive reactivity has for the patient, family
members, and caregivers, aggression may also increase the risk of
co-morbid psychiatric conditions and/or suicide (59).
SUICIDE
Suicidal ideation and suicide attempts post-TBI have been
reported in numerous studies (60–63). One report indicates the
rate of suicide in TBI patients is 2.7–4 times higher than of the
general population, matched for sex and age (64). In addition,
continuous military operations in Afghanistan and Iraq in the
last decade have been found to be associated with increases in
mild TBIs and suicides among US military personal (65). From
the clinical picture, TBI patients have high rates of critical indica-
tors of suicide risk, including hopelessness (35%), suicide ideation
(23%), and suicide attempts (18%) (63).
Several studies have attempted to phenotype the association
between TBI and suicide behavior, and one of the findings was the
correlation between the severity of the injury and suicide behavior.
A more severe injury is associated with a greater chance for suicide
behavior (66–68). However, no correlation was found between
suicide behavior and the injury localization (66). In addition,
it was found that the risk of suicide following TBI is unceas-
ing; even 15 years after the injury (64). However, it is important
to mention that although studies frequently report suicidality is
a common neuropsychological response to TBI, several studies
in non-military populations did not find increased suicide risk
among TBI patients (69, 70). Therefore, further exploration of the
association between TBI and suicide behavior is warranted.
POST INJURY SYMPTOMS IN ANIMAL MODELS OF TBI
Primarily in the field of psychopharmacology, core clinical features
of psychiatric diagnoses in humans have been modeled in animals.
Table 2 lists the symptoms of human diagnoses and corresponding
animal tests that allow for measurement of that specific symptom
in laboratory animals. The data collected for this review is lim-
ited due to difficulty in determination of publications that did not
include the test name in the title, key words, or abstract. However,
this is intended as an overview of emotional systems testing in
rodents after TBI.
DEPRESSION
The two clinical hallmarks of a major depressive disorder are
anhedonia and behavioral despair (71). Anhedonia is a phenom-
enon in which there is a loss of interest in pleasure derived from
typically enjoyable experiences or activities. Behavioral despair is
manifested in rodents where there is a significant decline in the
animal’s effort to avoid or escape aversive situations (72). Specific
behavioral tests allow these clinical hallmarks to be evaluated in
laboratory animals.
Sucrose/saccharin preference
The sweet taste of sugar is a potent motivator both in humans and
rodents (73). An often-employed, non-operant method for assess-
ing hedonic sensitivity in rodents is the measurement of preference
for consuming sweetened fluids (sucrose/saccharin) over water
(74–76). Indeed, rodents will not only consume a freely avail-
able sweet solution, they will perform a variety of tasks to obtain
rewarding solutions: press levers, run down an alley, etc. In general,
rodents will work harder as the concentration of the sweet solute
is increased (73).
Rodents normally exhibit very high preferences for the sweeter
solution, but this preference diminishes after exposure to chronic
mild stress or when they exhibit other depression-like symptoms.
Willner and colleagues (74) proposed that reduced consumption
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Table 2 | Summary of human emotional systems and animal tests related to post-TBI symptoms in humans.
Emotional
system
Models of
human
symptom
Rodent test Test parameter TBI effect on
animal
performance
Number of
hours/days
TBI effect lasted
Reference
Depression-
like
symptoms
Anhedonia Sucrose/saccharin
preference
Preference for consuming
sweetened fluids (sucrose/
saccharin) over water
Inconclusive 7–30 days post
injury
Jones et al. (79), Cope et
al. (80)
Anhedonia Female urine-sniffing
test
Preference for sniffing
estrus female urine odor
over water
No studies Not applicable
(N/A)
N/A
Despair
behavior
Porsolt swim test Measurement of swimming
activity during 6 min of the
test
Inconclusive 7–90 days post
injury
Milman et al. (81), Taylor et
al. (82), Tweedie et al. (83),
Jones et al. (79),
Schwarzbold et al. (84),
Wang et al. (85),
Washington et al. (86),
Shultz et al. (87), Kimbler
et al. (88)
Despair
behavior
Tail suspension test Measurement of struggling
behavior during 6 min of the
test, while the mouse is
suspended by its tail
No effect 7 and 30 days
post injury
Ando et al. (89), Vuckovic
et al. (90)
Anxiety-like
symptoms
Anxiety Elevated-plus maze Measuring the time spent in
the open arm of the arena
vs. the closed arms
Inconclusive 5–14 days post
injury
Cutler et al. (91), Pandey et
al. (92), Schwarzbold et al.
(84), Shultz et al. (87),
Washington et al. (86)
Anxiety Zero maze Measuring the time spent in
the area behind the walls vs.
the open area
Inconclusive 17 days–7 weeks
post injury
Ajao et al. (93), Siopi et al.
(94), Tucker et al. (95)
Anxiety Light/dark test Measuring the time spent in
the dark area of the arena
vs. the lit area
One study;
less time in
light chamber
∼1 week post
injury
Cope et al. (80)
Anxiety and
spontaneous
activity
Open field The total distance traveled is
measured (in cm); In
addition, the relative
amounts of time that a
mouse or rat spends in the
center of the open field area
versus the peripheral region
may also be a valid measure
of anxiety
Inconclusive in
rats; “hyperac-
tivity” in
mice
Increased activity
−24 h–7 days
post injury
Decreased activ-
ity – 10–14 days
Tendency to
spend less time
in the center
O’Connor et al. (96),
Fromm et al. (97), Wagner
et al. (98), Tweedie et al.
(83), Jones et al. (79),
Pandey et al. (92), Wakade
et al. (99), Schwarzbold et
al. (84), Tucker et al. (95),
Kimbler et al. (88), Yu et al.
(100), Budinich et al. (101),
Tucker et al. (102)
Irritability-like
behavior
Irritability Resistance to
capture or attempts
to struggle while
being restrained
The extent and duration of
struggling behavior is used
to measure irritability
No studies N/A N/A
Responsiveness to
uncomfortable
stimuli
Reactivity to the stimuli
Aggression Aggression Resident-intruder
test
Measurement of aggressive
behavior: attack bites; tail
rattling; wrestling; chasing
behavior; attack latency; in a
5-min of the test
One study:
impaired social
behavior
2 and 4 weeks
post injury
Semple et al. (103)
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of sweet solutions by rats after chronic mild stress is a mea-
sure of anhedonia. Interestingly, studies have found that different
kinds of stressors had distinctive effects on saccharin consump-
tion in rats. Physical (foot shocks) stress resulted in rats having a
reduced preference for saccharin solution, while after emotional
stress (presence in the adjacent compartment during foot shock
treatment of their cage mate), animals displayed a slight increase
in sweet solution preference (77).
A variety of saccharin/sucrose preference tests have been
described, but the tasks are fundamentally the same. The ani-
mal is presented with two bottles; one bottle contains tap water
and the other a sweet solution (saccharin or sucrose; the con-
centration is determined according to the strain of the animals
and the lab protocol, and varies from 0.004 to 0.35%). The ani-
mals have the opportunity to drink as much of the solution
or water as they want during a significant amount of time (at
least overnight). The bottles are weighed before they have been
introduced to the animals and again at the end of the experi-
ment, and a preference ratio is calculated (consumed sweetened
solution)/(consumed water+ consumed sweetened solution). The
preference for sweet solution over water exhibited by the rodent
is used as a measure for sensitivity to reward (76). Although the
sweet solution preference test is widely used, it has limitations.
Forbes and colleagues (78) showed that reduced consumption of
sweet solution in stressed rats might result solely from diminished
body weight, rather than stress per se, and concluded that sucrose
consumption cannot be used as a valid test for hedonic responsive-
ness. In addition, differences in this test may result from alterations
in the gustatory system and appetite by gene manipulation and/or
pharmacological treatment, and may not truly indicate a change
in the reward-seeking state.
Jones and colleagues (79) have explored the effects of TBI on
depressive-like symptoms in rats (lateral fluid-percussion injury
model; ∼3.5 atmosphere pressure pulse directed to the right
sensorimotor cortex), and found that there were no significant
differences between injured rats and sham controls in the sucrose
preference test, 1, 3, and 6 months after the primary injury (79).
On the other hand, Cope and colleagues found that TBI rats [con-
trolled cortical impact (CCI) to the frontal cortex; 5 mm impactor
tip, 3 mm depth, 2.25 m/s, impact time 500 ms] showed a signif-
icantly lower preference for saccharin compared to the control
sham rats 8 days following injury (80). The number of studies
using the sweet solution preference test in rodent models of TBI is,
unfortunately, very limited, and therefore it is premature to assert
the utility of this measure for TBI rodent models.
Female urine-sniffing test
The female urine-sniffing test (FUST) is a non-operant method
that measures hedonic behavior using a sexual incentive (104). The
FUST procedure combines two previous areas of investigation: the
olfactory habituation/dishabituation test (72, 105, 106) and the use
of estrus urine or bedding as a sexual incentive (107, 108). Studies
have shown that estrus female rodent urine extracts elicit specific
behavioral displays analogous to those observed in the presence of
reward incentive stimuli: increased number of approaches, longer
time spent with the stimulus, and shortened approach time to the
stimulus [for review, see Ref. (109)].
One hour prior to the test, rodents are habituated to a sterile
cotton-tipped applicator inserted into their home cages. After 1 h,
the sterile cotton-tipped applicator is removed and each rodent,
separately, is transferred to a dimly lit room (∼3 lux lighting). The
FUST has three phases: (1) water – one exposure (3 min) to a cot-
ton tip dipped in sterile water, during which sniffing duration is
measured; (2) habituation – the rodent cage is transferred from the
experiment room to an habituation area for an interval of 45 min
during which no cotton tip is presented; and (3) urine – the ani-
mal is transferred back to the experiment room for one exposure
(3 min) to a cotton tip applicator infused with fresh urine collected
from females in estrus (of the same strain), and sniffing duration
is measured.
The FUST has been validated in several rodent strains
(C57BL/6J mice, 129S1/SVImJ mice, and Wistar-Kyoto rats). It has
been employed with several pre-clinical experimental paradigms
including, learned helplessness (LH) (110), to evaluate the effects
of chronic treatment with a selective serotonin-reuptake inhibitor
(SSRI) with mice that experienced the LH (104), after single elec-
tric shock stress manipulation (104), and with a mouse strain
(GluR6KO) that exhibits manic-like symptoms (111). GluR6KO
males spent a significantly longer duration sniffing female urine
compared to wild-type control mice (104). The FUST is suitable
and well validated for measuring hedonic-like behavior in male
rodents. However, due to the novelty of the test and the short time
of its existence, there are no available data for the effects of TBI in
mice or rats.
Porsolt forced swim test
The forced swim test was developed by Porsolt and colleagues
(112) and has become widely used for the study of rodent mod-
els of depression or “behavioral despair” (113), response to stress
(114), and as a tool for screening antidepressant drugs (112, 115,
116). In the forced swim test, the rodent is placed in a cylin-
der filled with water with no ability to escape. Typically, animals
initially paddle vigorously, but then become relatively immobile
(defined as a lack of activity except movements needed to keep the
nose above water), and finally may adopt a characteristic vertical
floating response. Abel (116) has demonstrated that the vertical
immobility response in the forced swim test has a sudden ontoge-
netic onset, beginning at 21 days of age and quickly stabilizing at
26 days of age.
The procedure may vary for mice and rats. Mice are only
immersed once into the cylinder of water for session durations
between 4 and 20 min [see Ref. (72) but also, see Ref. (117)], in
which a pre-exposure period of 2–5 min is conducted before the
swimming activity is measured. Rats usually are immersed twice
in the water cylinder where initially the rats are immersed for
10 min, in which no measurements are taken. Twenty-four hours
later, rats are re-immersed for 6 min and swimming activity is
evaluated. However, in some variations of the test, rats are only
immersed once and immobility time is recorded during this single
session (118–120).
Several studies have found that prepubertal and adult rodents
exhibiting depression-like symptoms on several behavioral tests,
such as the saccharin preference, also exhibited longer immobility
duration in the Porsolt swim test (114, 121–123). This increased
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immobility duration can be altered by acute and chronic anti-
depressant treatment (121, 124, 125), making the Porsolt forced
swim test appropriate for the study of depression-like symptoms
in rodents.
Compared to the sweet solution preference tests and the FUST,
the swim test has been frequently employed to evaluate rodent
performance after TBI. Milman and colleagues (81) found that
injured mice showed significantly greater durations of immobility
compared to sham controls 7 and 90 days after TBI induced by a
weight-drop device (metal weight of 30 g dropped vertically from
80-cm height). Taylor and colleagues (82) found that after 8 weeks,
rats with TBI induced by CCI (left parietal cortex; 5 mm diame-
ter impactor tip; 28 psi pressure; 2.75 m/s for 250 ms) exhibited
significantly less swimming behavior compared to the sham con-
trols; also suggesting depression-like symptoms in brain-injured
rodents. In addition, clear differences between Imprint Control
Region (ICR)-strain mice with a mild TBI (induced by a 30 or
50 g metal weight dropped from a height of 80 cm) and their sham
controls were found in a study conducted by Tweedie and col-
leagues (83), where injured animals spent a longer time immobile
when tested 3 days after the injury. Lastly, Washington found CCI
(3.5 mm tip, 5.25 m/s speed, 0.1 s dwell time, 1.5–2.5 mm depth)
resulted in a significant increase in immobility time 21 days after
injury (86). It is noteworthy to mention that several studies have
not found any significant differences in the forced swim test after
TBI. Jones and colleagues (79) found no difference in swimming
activity between sham controls and rats receiving a TBI to the
right sensorimotor cortex (lateral fluid-percussion injury; ∼3.5
atmosphere pressure pulse) 6 months post-TBI. Schwarzbold and
colleagues (84), did not find a significant difference between TBI
mice and their sham controls, 10 days after the injury induction
(weight-drop TBI device, weights varies between 10 and 15 g, with
a diameter of 3 mm, and dropped from 120 cm height on the left
parietal region). Wang and co-investigators examined the effect
of moderate to severe TBI (−2.0 mm AP and 2.0 mm ML rela-
tive to the bregma suture) of C57BL/6 mice, produced by CCI
(2.0 mm diameter tip; 1.5 m/s velocity; 1.25 mm depth; 155 ms
contact time),and found no difference between brain-injured mice
and their sham controls in the forced swim test, 4 weeks post injury
(85). Shultz found that only after five injuries by fluid percussion,
mice exhibited an increase in immobility score 8 weeks post injury
(87). Kimbler observed that, surprisingly, CCI (4.5 m/s, 20 ms
dwell time, 1 mm depth, 3 mm diameter impactor tip) lengthened
the latency to immobility 72 h after injury (88).
The causes for different outcomes from TBI may be related
to an oft-cited problem in behavioral research in general; labora-
tories employ different experimental conditions. Test procedures
vary across studies, different strains of animals were used, the time
after injury when rodents were evaluated, and the procedure for
inflicting TBI and the location of the injury differs across labora-
tories. Thus, further studies are needed to assess the impact of TBI
on performance on the forced swim test.
Tail suspension test
The tail suspension test has been employed as a measure of
depression-like behavior (126). As in the case of the Porsolt swim
test, this test is based on the assumption that the emotional state
of an animal will influence their efforts to escape an aversive sit-
uation, and that the internal states relates to the duration of the
escape response (72). In this test, the aversive situation accrues
while the mouse is being suspended by the tail, usually for 6 min,
while the body suspends in the air facing downward. The dura-
tion of struggling to face upward and reach for a solid ground
is recorded and compared between mice/strains. Usually, a naïve
mouse will struggle for several minutes, but eventually stops mov-
ing and remains immobile for the remaining time of the testing
session (72).
Few TBI studies have employed the tail suspension test, and
further study is needed to determine the effect of TBI on the
rodent’s behavior in this test. Ando and colleagues (89) found
that CCI (2 mm tip; 4.5 m/s velocity; 2 mm depth; 80 ms con-
tact time) followed by laser treatment reduced immobility time
with the tail suspension test 4 weeks after the injury, but the study
did not include a sham-treated or naïve control group for com-
parison. Brain injury by exposure to 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP) was found to have no impact upon
the performance on the tail suspension test 7 and 30 days post
injury compared to the control group (90).
ANXIETY
Several established procedures for measuring emotional reactivity
and anxiety-like symptoms in rodents are based on approach-
avoidance situations where anxiety alters responses to a conflict
inherent in the test setting (72). Here, we will review the most
well-known tests.
The elevated-plus maze
The elevated-plus maze (EPM) is a widely employed measure in
anxiety research (127) and an accepted procedure for drug discov-
ery in pharmaceutical companies (128). Rodents have a natural
tendency to explore novel environments, but brightly lit, open,
elevated areas are perceived by the animal as aversive. The EPM
measures the naturalistic conflict between these two features (129).
The maze is usually constructed of Plexiglas in a plus-shaped
formation with two dark, enclosed arms and two open well-
lit arms, elevated 50–100 cm above a table surface or floor.
The dimensions of the arms are usually 30 cm× 5 cm with a
5 cm× 5 cm center area, and the walls of the closed arms are
∼40 cm high. A single mouse is placed in the center of the maze
for 5 min, and usually tracked with a video camera. The time spent
in the three different areas of the maze (closed arms, open arms,
and center) and the frequency of visits to these different zones is
scored manually or by the use of automated software. Compared to
control animals, rodents exhibiting anxiety-like behaviors spend
more time in the closed arms of the apparatus than in the open
arms. The validity of the test is supported by studies that show
performance is sensitive to anxiolytic and anxiogenic compounds:
anxiolytic drugs (e.g., benzodiazepines) typically increase the per-
centage of time spent in the open arms relative to time spent in
the open and closed arms together, anxiogenic drugs decrease the
amount of time the animals spend in the open arms (127, 130).
Schwarzbold and colleagues (84) found that mice 11 days after
a TBI induced by a 10-g weight dropped on the left parietal
region (from a height of 120 cm) exhibited a significant decrease
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in entries into the open arms, and spent less time in the open
arms (anxiety-like behavior) compared to sham controls and to
mice with TBI induced by 12.5 and 15 g weight dropped on the
same brain region, suggesting that a mild TBI, but not more severe
injuries, may result in an elevated anxiety response. On the other
hand, Pandey and colleagues (92) found that 14 days after a mild
TBI (400 g weight, 10 mm diameter, dropped from a height of 1 m
on the exposed skull, mid-distance between lambda and bregma
sutures), rats exhibited a significant increase in both percentage
of open-to-total arm entries and percentage of total time spent
in the open arms when compared with rats that underwent sham
surgery. Although both of the latter studies have used different
species, each claimed to induce “mild” TBI by using the weight-
drop procedure. However, the parameters used in these studies
are substantially different, and hence may underlie the differ-
ences in behavioral results. An estimate of kinetic energy of the
weight drop in the Pandey study (92) indicates it may have been
three-times greater than what was employed in the Schwarzbold
experiment (84).
Cutler and colleagues (91) found no difference in EPM per-
formance between vehicle-repeated injections treated injured rats
induced by CCI (5 mm diameter; 1.7 psi; 50 ms; 2.25 m/s) and
vehicle-repeated injections treated sham controls 5–6 days after
injury. But, rats induced by CCI and vehicle treated in silastic cap-
sule implantations spent more time in the open arms compared
to vehicle treated in silastic capsule implantations sham controls.
In addition, Shultz and colleagues (87) used the EPM and found
that repeated fluid-percussion injury (FPI) resulted in a decrease
in time spent in the open arms at 24-h and 8 week timepoints post-
TBI (87). Washington and colleagues (86) measured the duration
of mouse exploration in the open arms 21 days after TBI, and
found that mild, moderate, and severe TBI animals (induced by
CCI) spent a significantly greater amount of time in the open
region – hence, showing reduction in anxiety-like behavior and
increase in risk-taking-like behavior (86), compared to their con-
trols, with no effect related to the extent of the injury. Thus, the
effect of TBI on anxiety-like behavior in the EPM in mice and rats
is unclear and further studies are needed.
Zero maze
Considered a “modification” of the EPM, the zero maze has been
used to evaluate anxiety-related behaviors in rodents (131), and in
the last year has seen utility in rodent model studies of TBI (93–95).
Similar to the EPM, the zero maze is brightly lit, with alternation
between dark areas surrounded by walls, and open areas along an
elevated circular runway. As opposed to the EPM, the zero maze
has no central start box, in which mice often remain for signifi-
cant periods of time; hence avoiding the ambiguity in scoring arm
entries and reducing variability of the data (72).
Ajao and colleagues report that when 17 day-old rats sustained
CCI (3-mm diameter impactor, 1.5 mm depth, 200 ms duration at
6 m/s velocity), they exhibited an increase in time spent in the dark
(walled) regions of the maze compared to sham-treated animals
60 days after injury (93). Siopi and colleagues performed weight-
drop injuries (50 g weight, dropped from 36 cm height) on mice
and compared their performance to naïve-treated animals (94).
Injured mice exhibited no change in the percentage of time or the
number of entries into the open portion of the zero maze, but
they exhibited a greater number of U-turns, 7 weeks post injury.
Tucker and coworkers exposed male mice to a single 900 mV, 10 ms
wave generated from a high intensity focused ultrasound device
(95). Ultrasound exposed mice exhibited reduced time in the open
regions of the zero maze 4 days post injury, compared to sham-
treated animals. Overall, it seems that TBI has an anxiolytic-like
effect on rodent behavior in the zero maze test, but further study
is needed.
Open field test
The open field test, originally developed by Hall (132), has become
one of the most frequently employed tests for measuring sponta-
neous activity (72). Investigators have traditionally employed this
test as a measure of “emotionality” (132–134). In the open field
procedure, the animal is initially placed in the center of the appa-
ratus (usually 40 cm× 40 cm× 30 cm; W× L×H box) and the
following behaviors are recorded for 2–20 min: horizontal loco-
motion, frequency of rearing, grooming, freezing, number of fecal
boli deposited, and the proportion of time spent in the center of
the arena (72).
In addition to being the most widely used assessment of gen-
eral activity, the open field test was one of the earliest tools that
was applied to evaluate the incidence of freezing and defecation as
measures of anxiety-like behaviors (135, 136). The relative amount
of time that a mouse or rat spends in the center of the open field
area versus the peripheral region is likewise considered a mea-
sure of anxiety; rodents are exploratory but will generally stay
near the walls of the open field [for review, see Ref. (72, 137)].
There are two naturalistic factors that trigger anxiety-like behav-
iors in the open field: agoraphobia (the arena is very large relative
to the animal’s natural environment) and individual testing (the
animal is separated from its social group). These two factors trig-
ger anxiety-like behavior in rodents that live in social groups and
in small tunnels (138). Pharmaceutical agents such as benzodi-
azepines, serotoninergic ligands, opiates, and dopaminergic agents
all decrease anxiety-like behaviors of rodents in the open field, sug-
gesting that this test is appropriate for studying anxiety in mice and
rats (139–142).
Many studies have explored the effects of TBI on motor activity
and anxiety-like behaviors of rodents in the open field. Rats with
a TBI in the right parietal cortex induced by CCI (6 mm impact
tip diameter; velocity 4 m/s) were no different than sham controls
13 days after injury on measures of activity and exploratory behav-
ior in the open field (98). Another study (79) employed the FPI
model and also found no significant differences between injured
rats (FPI −4 mm lateral and 4 mm posterior to bregma; 3.2–3.5
atmospheres of pressure pulse over 21–23 ms) and their controls.
These animals were evaluated for the total distance traveled in the
apparatus, 1, 3, and 6 months after injury. However, injured rats
spent less time exploring the center of the open field compared
to sham controls, suggesting some difference in level of anxiety as
a function of FPI. Fromm and colleagues (97) showed that TBI
rats, induced by a 450-g weight dropped from a 2-m height on a
10-mm diameter disk (placed on the exposed skull, between the
lambda and bregma sutures), exhibited significantly less sponta-
neous activity in the open field 7 days post injury, compared to
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pre-injury results. Using the same injury method and parame-
ters, measures found injured rats performed significantly poorer
in activity measurements as well as anxiety-like behavior measure-
ments. TBI animals were more stationary; traveled less distance in
the arena; less explorative; explored only the corners of the appa-
ratus. Another study, using similar weight-drop parameters, found
persistent decreased open field activity for up to 4 weeks after
injury (96). As opposed to the studies mentioned above, Pandey
and colleagues (92) found that injured rats exhibited increases in
several activity parameters in the open field model, 14 days after
injury induction, compared to their sham controlled rats.
Activity level changes in mice follow a more consistent pat-
tern. Wakade and colleagues (99) found that CD-1 mice, 7 days
following a moderate TBI induced by CCI (3.5 mm craniotomy
midway between the bregma and lambda), exhibited hyperactivity
in the open field test, compared to their sham controls. Kim-
bler and colleagues observed that CCI-injured mice exhibited an
increase in distance traveled compared to sham-operated animals
3 days after injury (88). Yu and colleagues examined the effects
of brain injury 10 days after post-CCI (3 mm tip, 2 mm depth,
5 m/s); the injury resulted in mice that were hyperactive in terms
of distance traveled, but the animals spent less time in the center
(100). Budinich and colleagues reported that CCI (3 mm impactor,
1.0 mm depth of impact, 5 m/s, dwell time of 0.1 s) caused mice
to exhibit increased mobility on 1, 7, and 14 days after injury,
but that they spent less time in the center of the open field (101).
Similar instances of “hyperactivity” have been observed in our lab-
oratory for several weeks post-TBI: Tucker and colleagues (102)
studied mice that sustained either mild (impact depth 1.0 mm) or
severe (depth 2.0 mm) CCI (3 mm impactor tip, velocity 5 m/s).
Schwarzbold and colleagues found similar results: 10 days after
TBI induction, injured mice (of the 15-g weight group) exhibited
higher locomotor activity compared to mice from other control
groups (84). Animals that sustained severe CCI were hyperactive
with less time spent in the center. Following mechanical stimula-
tion by HIFU, however, animals were hypoactive in the open field
(95) for at least 1 week post-TBI. Likewise, Tweedie and colleagues
found no differences between sham-treated and injured mice in
the percentage changes in distance traveled by mice 3 days after
TBI (83).
The results from rat studies, regarding activity measurements in
the open field test after TBI induction, are inconclusive. It is impor-
tant to note that different laboratories do not only use different
models of TBI, but also use different strains of rats (e.g., CD-1,
Wistar, Sprague-Dawley, etc.). Therefore, additional research of
the effect of TBI on activity, as well as on anxiety-like behavior in
the open field test is essential. For studies with TBI in mice, there
is greater consistency in findings where the general finding is an
increase in activity.
Light/dark test
Analogous to the elevated-plus maze, the light/dark test is based
on the conflict between the tendency of mice to explore a novel
environment versus the aversive properties of a brightly lit open
field (143). The typical dimensions of the light/dark test appara-
tus for mouse use are 46 cm× 27 cm× 30 cm (L×W×H) and
it is divided into two parts: an opaque, covered chamber, con-
sidered by a rodent to be the “safe” compartment (approximately
one-third of the apparatus), and a larger, illuminated “aversive”
compartment, which is a transparent, uncovered arena that is illu-
minated by an overhead lamp. Rodents that exhibit anxiety-like
behavior will spend significantly more time in the dark, “safe”
compartment compared to their controls. Crawley and Goodwin
(143) showed that anxiolytic drugs (benzodiazepines) facilitated
exploratory behavior; mice spent more time in the illuminated
open area as a result of the treatment. Indeed, multiple subsequent
studies have shown that anxiolytic drugs increase locomotion and
time spent in the light “aversive” compartment, while anxiogenic
compounds decrease locomotion and time spent in this com-
partment [for review, see Ref. (144)]. Few studies appear to have
investigated the effects of TBI on the behavior of rodents in the
light/dark test. Cope and colleagues report that TBI rats (induced
by CCI to the medial frontal cortex) spent less time in the lighted
arena and made fewer crossings between the different zones 8 days
after injury (80), exhibiting anxiety-like behavior.
IRRITABILITY
“Irritability” has been recognized as a state that can be evalu-
ated in rodents. It has been described as a condition where the
animal exhibits “wild” and/or restlessness in response to a per-
ceptible stimulus (145), and as an extreme reaction to relatively
mild stimuli (146). However, as opposed to aggression and impul-
sivity, irritability – in humans – is not just behaviorally defined,
but involves subjective state changes (147); therefore, the model-
ing of irritability in rodents is conceptually complicated. A variety
of drugs such as parachlorophenylalanine (148) and trimethyltin
(149), and imidazole (150) can provoke this state. Likewise, psy-
choactive drug withdrawal, especially for opiate drugs, reportedly
most robustly elicits this state (151, 152).
The two most commonly used tests for evaluation are resistance
to capture or attempts to struggle while being restrained (153), and
responsiveness to uncomfortable stimuli. Tests also include assess-
ing rodent struggling behavior in response to human handling. As
a response to moderate restraint applied by the handler, a mouse
will either exhibit a passive or irritated response. The extent and
duration of struggling behavior are used as metrics (153). Tests of
responsiveness to a uniformly uncomfortable situation have also
been employed. An uncomfortable stimulus is given (e.g., a white
bottle brush moving against the animal or a puff of air blown
sharply through a straw onto the back of the animal’s neck) and
the animal’s response is quantified. Animals that exhibit enhanced
reactivity to the stimuli are considered to display irritable behavior
(146). Irritability as a post-TBI symptom is undoubtedly impor-
tant clinically and testing in animal models may shed light on this
complex symptom. However, a review of the literature found no
studies that have examined this post-TBI.
AGGRESSION
Beginning in the juvenile phase of development, rodents establish
dominance hierarchies, and engage in fighting behavior (154).
Indeed, rodent aggression behavior has been described in detail
in many laboratories (155). Experts suggest laboratory studies
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with rodents mirror at least some aspects of aggression in humans
(156). Several behavioral tests assess aggression in rodents, includ-
ing the tube test (157) and the standard opponent method
(158). However, the most widely employed assessment is the
resident-intruder test (159).
Resident-intruder test
In the resident-intruder test, an “intruder,” usually a naïve, weight-
and age-matched mouse (weight and age are crucial components
affecting aggression behavior in rodents), is placed into “the home
cage,” that the experimental mouse has been housed in for an
extended period of time: the intruder elicits territorial attacks from
the male resident in the home cage (72). Usually, a 5-min resident-
intruder session is conducted [although test sessions vary from 2 to
30 min (160)] and videotaped recordings are used for subsequent
scoring by the investigator. The investigator scores the frequency
and the length of the following behaviors: attack bites – biting of
the intruder mice; tail rattling – rapid lateral quivering of the tail,
just before or after attacking; wrestling – vigorous shoving and
sparring when both animals take on an upright posture, usually
performed by both animals simultaneously; chasing behavior –
rapid pursuit of the intruder by the test male, with or without
physical contact; and attack latency – latency time to the first attack
(in seconds) from the introduction of the intruder mouse.
Numerous studies have found that acute (but not chronic)
treatment with antidepressants has been able to reduce aggres-
sive behavior in the resident-intruder test in rats, including: SSRIs,
serotonin-norepinephrine reuptake inhibitors, monoamine oxi-
dase inhibitors (MAOIs), tricyclic antidepressants (TCAs) and
atypical antidepressants such as mainserin and iprindole (161).
Mouse aggressive behavior, on the other hand, has been found
to be sensitive to anxiolytic drugs rather than antidepressants
in the resident-intruder test (162). Lumley et al. (162) proposed
that this difference in response between mice and rats is due to
the functional differences in aggressive behavior between these
species: while mice violently defend their territory, rats live in
social colonies where excessive agonistic behavior is harmful to
the social group.
Semple and colleagues (103) evaluated social behavior, includ-
ing aggressive behavior, in mice subjected to TBI at post-natal day
(pd) 21. The resident-intruder test was conducted twice – once in
the adolescence phase (pd 35–42) and during early adulthood (pd
60–70). The researchers found that despite normal olfactory func-
tion and normal social behavior during adolescence, injured mice
exhibited impaired social investigation in the resident-intruder test
by adulthood; injured mice displayed reduced anogenital sniffing
and following compared to their controls. In addition, by adult-
hood, injured mice showed more frequent dominance in the tube
task compared to their sham controls, suggesting aggressive ten-
dencies in the TBI mice. No studies have been conducted on the
effect of TBI on aggression behavior in rats. However, lesion stud-
ies have been a classic approach for delineating systems related to
aggression and integration with this field is warranted (163, 164).
SUICIDE
Suicide is a complex human behavior and is an aftereffect in many
cases of TBI. Unfortunately, there are no existing animal models
for suicide per se. Studies have tried to identify personality traits
that are risk factors for suicidal behavior (165, 166), and the four
major risk factors that have been found to be common for most
of the studies were aggression, impulsivity, irritability, and hope-
lessness/helplessness [for a thorough review of these risk factors
and their animal models, see Ref. (161)]. As reviewed earlier, all of
these behaviors are amenable to modeling in rodents, providing
an opportunity to determine neurobiological mechanisms relating
brain injury and suicidality.
SUMMARY
The simulation of TBI-relevant neuropsychiatric symptoms in
pre-clinical rodent models is a critical step for further under-
standing basic molecular and structural relationships and for the
development of therapeutic approaches. As noted earlier, some
symptom profiles in the realm of motor and cognitive function
have received wide employment in pre-clinical TBI research. For
example, this literature review found popular and suitable motor
tests include the beam walk test, rotarod, and neurological assess-
ment scales. Likewise, the Morris water swim test and open field
test are conventionally employed for cognitive assessment. Neu-
ropsychiatric impairments have received less attention in animal
models of TBI and are recognized as a challenge. Table 2 summa-
rizes the status of emotional systems testing in rats and mice after
TBI. The literature suggests“hyperactivity” is seen in the open field
test in mice after TBI, and one study found anxiety responses in the
Light/Dark Test. One study has employed the Resident-Intruder
Test as a measure of aggression and social behavior. However,
few tests were found that employed other tests of emotional sys-
tems that have received quite wide use in the psychopharmacology
field.
Rodent models cannot replicate “higher” cognitive-emotional
reactions and expectations of individuals and their social milieu,
and how the patient must learn to cope with the knowledge
of personal mental and/or physical impairment(s) and poten-
tial limitations in adjusting to life’s many challenges. Animal
models, then, have limitations in ability to fully mimic the
human condition. Likewise, “There is no way for a human
investigator to know whether a mouse is feeling afraid, anx-
ious, or depressed. . . . What we can do is observe the behav-
ioral and physiological responses that a mouse makes to stim-
uli and events” (72). In spite of limitations, neuropsychiatric
symptomatology from TBI related to depression, anxiety, irri-
tability, and aggression are major aspects of human suffering, and
require continued and concerted efforts related to etiology and
therapeutics.
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